Cargando…
Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
BACKGROUND: Schistosomiasis is a neglected tropical disease caused by trematodes of the genus Schistosoma, with a limited treatment, mainly based on the use of praziquantel (PZQ). Currently, several aspartic proteases genes have already been identified within the genome of Schistosoma species. At le...
Autores principales: | Gomes, Bárbara Figueira, Senger, Mario Roberto, Moreira-Filho, José Teófilo, de Vasconcellos, Fabio Jorge, Dantas, Rafael Ferreira, Owens, Raymond, Andrade, Carolina Horta, Neves, Bruno Junior, Silva-Junior, Floriano Paes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481938/ https://www.ncbi.nlm.nih.gov/pubmed/37672425 http://dx.doi.org/10.1590/0074-02760230031 |
Ejemplares similares
-
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020) -
QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018) -
Signaling Functions of Intramembrane Aspartyl-Proteases
por: Papadopoulou, Alkmini A., et al.
Publicado: (2020) -
Plasmepsin-like Aspartyl Proteases in Babesia
por: Šnebergerová, Pavla, et al.
Publicado: (2021) -
Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
por: Konstantinidou, Markella, et al.
Publicado: (2020)